Comparison of Post-operation Cardiopulmonary Capacity of Patients Underwent Conventional and Robot-assisted Coronary Artery Bypass Graft and Valve Replacement Surgery

September 2, 2025 updated by: Taichung Veterans General Hospital
Robotic surgery is one of the most popular minimally invasive procedures for patients with coronary artery disease or valvular diseases. Studies have shown that, as compared to conventional sternotomy, patients underwent robot-assisted bypass grafting or valvuloplasty had less post-operation pain, blood transfusion volume during operation, re-operation rate, post-operation stroke rate and length of hospitalization. However, most studies focused on the comparison of complications of different procedures, and the investigation of cardiopulmonary function recovery is still lacking. Thus our study is to compare the functional outcomes between patients that undergo different surgical procedures.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

The study is a prospective cohort study. The experimental group will include 40 patients, consisting 20 after robotic coronary artery bypass grafting and 20 after robotic valvuloplasty. The control group will include 20 patients for each conventional procedure.

Once decided the surgery type, the surgeon will consult the rehabilitation department and the director of this trial for inform consent. The recruitment and allocation will only be done after the patient has decided which type of surgery to receive. However, in case of change of surgery type, the patient will be excluded from the trial.

Cardiopulmonary exercise testing, 6-minute walking test and questionnaires about wound pain and cardiac functional status will be performed before surgery, two weeks after discharge and three months after discharge respectively. Primary outcomes include the change of maximal oxygen consumption (VO2), anaerobic threshold and the result of six minute walking test before and after surgery. Secondary outcomes include the change vital capacity (FVC), resting heart rate, oxygen pulse (O2 pulse), wound pain visual analog scale (VAS) and Duke Activity Status Index (DASI) before and after surgery.

The hypothesis of this study is that patients who undergo robot-assisted surgery will have better cardiopulmonary outcomes than those receive conventional surgery

Study Type

Observational

Enrollment (Estimated)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Taiwan
      • Taichung, Taiwan, Taiwan, 40705
        • Department of Physical Medicine and Rehabilitation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

coronary artery and valvular heart disease patients

Description

Inclusion Criteria:

  • patient who undergo surgery for coronary artery bypass graft or valvular replacement.

Exclusion Criteria:

  • pregnant
  • patients who receive more than one type of surgery
  • severe complications after surgery (ex. respiratory failure, stroke) and stayed in hospital for more than 2 weeks.
  • cannot perform the cardiopulmonary exercise testing
  • other contraindications for cardiopulmonary exercise testing

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
bypass graft, sternotomy
patients who have received coronary artery bypass graft surgery with conventional sternotomy procedure
bypass graft, robot
patients who have received coronary artery bypass graft surgery with robot-assisted procedure
  1. traditional sternotomy for coronary bypass graft or valvular replacement
  2. robot-assisted surgery for coronary bypass graft or valvular replacement
Other Names:
  • sternotomy
valvular heart disease, sternotomy
patients who have received valvular replacement surgery with conventional sternotomy procedure
valvular heart disease, robot
patients who have received valvular replacement surgery with robot-assisted procedure
  1. traditional sternotomy for coronary bypass graft or valvular replacement
  2. robot-assisted surgery for coronary bypass graft or valvular replacement
Other Names:
  • sternotomy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of maximal oxygen consumption post-surgery
Time Frame: pre-operation to 2 weeks post-operation
the change of maximal oxygen consumption from surgery before to 2 weeks after surgery
pre-operation to 2 weeks post-operation
Change of maximal oxygen consumption in 3 months
Time Frame: pre-operation to 3 months post-operation
the change of maximal oxygen consumption from before surgery to 3 months after surgery
pre-operation to 3 months post-operation
Change of anaerobic threshold post surgery
Time Frame: pre-operation to 2 weeks post-operation
the change of the onset of lactate accumulation in blood from before surgery to 2 weeks after surgery
pre-operation to 2 weeks post-operation
Change of anaerobic threshold in 3 months
Time Frame: pre-operation to 3 months post-operation
the change of the onset of lactate accumulation in blood from before surgery to 3 months after surgery
pre-operation to 3 months post-operation
Change of six minute walking test result post-surgery
Time Frame: pre-operation to 2 weeks post-operation
the change of six minute walking test result from before surgery to 2 weeks after surgery
pre-operation to 2 weeks post-operation
Change of six minute walking test result in 3 months
Time Frame: pre-operation to 3 months post-operation
the change of six minute walking test result from before surgery to 3 months after surgery
pre-operation to 3 months post-operation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of vital capacity post-surgery
Time Frame: pre-operation to 2 weeks post-operation
the change of vital capacity during pulmonary function testing from before surgery to 2 weeks after surgery
pre-operation to 2 weeks post-operation
Change of vital capacity in 3 months
Time Frame: pre-operation to 3 months post-operation
the change of vital capacity during pulmonary function testing from before surgery to 3 months after surgery
pre-operation to 3 months post-operation
Change of respiratory flow post-surgery
Time Frame: pre-operation to 2 weeks post-operation
the change of the ratio of air volume on exhalation to vital capacity during the first second in the pulmonary function testing from before surgery to 2 weeks after surgery
pre-operation to 2 weeks post-operation
Change of respiratory flow ratio in 3 months
Time Frame: pre-operation to 3 months post-operation
the change of the ratio of air volume on exhalation to vital capacity during the first second in the pulmonary function testing from before surgery to 3 months after surgery
pre-operation to 3 months post-operation
Change of resting heart rate post-surgery
Time Frame: pre-operation to 2 weeks post-operation
the change of resting heart rate from before surgery to 2 weeks after surgery
pre-operation to 2 weeks post-operation
Change of resting heart rate in 3 months
Time Frame: pre-operation to 3 months post-operation
the change of resting heart rate from before surgery to 3 months after surgery
pre-operation to 3 months post-operation
Change of oxygen pulse post-surgery
Time Frame: pre-operation to 2 weeks post-operation
the change of the maximal value of VO2 divided by heart rate during exercise testing from before surgery to 2 weeks after surgery
pre-operation to 2 weeks post-operation
Change of oxygen pulse in 3 months
Time Frame: pre-operation to 3 months post-operation
the change of the maximal value of VO2 divided by heart rate during exercise testing from before surgery to 3 months after surgery
pre-operation to 3 months post-operation
pain post-surgery
Time Frame: 2 weeks post-operation
pain visual analog scale score (from 0 to 10, higher score means more painful) for surgery wound pain at 2 weeks after surgery
2 weeks post-operation
pain in 3 months
Time Frame: 3 months post-operation
pain visual analog scale score (from 0 to 10, higher score means more painful) for surgery wound pain at 3 months after surgery
3 months post-operation
Change of activity status post-surgery
Time Frame: pre-operation to 2 weeks post-operation

the change of the Duke Activity Status Index (DASI) score from before surgery to 2 weeks after surgery.

The DASI is a score ranging from 0 to 58.2. A higher score indicates a better cardiorespiratory fitness.

pre-operation to 2 weeks post-operation
Change of activity status in 3 months
Time Frame: pre-operation to 3 months post-operation
the change of the Duke Activity Status Index (DASI) score from before surgery to 3 months after surgery The DASI is a score ranging from 0 to 58.2. A higher score indicates a better cardiorespiratory fitness.
pre-operation to 3 months post-operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Yuchun Lee, MD, Taichung Veterans General Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 1, 2025

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

May 31, 2028

Study Registration Dates

First Submitted

May 29, 2022

First Submitted That Met QC Criteria

June 23, 2022

First Posted (Actual)

June 24, 2022

Study Record Updates

Last Update Posted (Estimated)

September 9, 2025

Last Update Submitted That Met QC Criteria

September 2, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Valvular Heart Disease

Clinical Trials on robot-assisted surgery

Subscribe